Mandate

VINGE ADVISES TOBII IN CONNECTION WITH THE LISTING ON NASDAQ STOCKHOLM

April 28, 2015

Vinge advises Tobii AB (publ) in connection with Tobii’s listing on Nasdaq Stockholm.

Tobii is the global leader in eye tracking, a technology that is used to gain insights in human behavior or as a means to interact with computers and other devices. The Swedish language prospectus was published on 13 April 2015 and the first day of trading was 24 April 2015. The offering price has been set at SEK 25 per share, corresponding to a market value of Tobii of approximately SEK 2.1 billion.

Vinge’s team primarily consisted of Jesper Schönbeck, Johan Winnerblad, Rikard Lindahl, Charlotta Järnstedt and Henrik Wastenson.

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025